Prime Therapeutics recognized as Star Tribune National Standard Top Workplace

This award recognizes the best places to work according to a company’s employees. The recognition was granted based on Prime’s benefit programs and offerings, community involvement opportunities and overall culture. It is also reflective of a progressive and innovative company mindset.

“We are proud to once again be named a Star Tribune Top Workplace,” says Erin Feigal, chief human resources officer. “We have a top-notch culture at Prime, and it’s great to see that our employees believe that too. Thank you to all of our employees – you make Prime an excellent place to work.”

The results were based on a voluntary employee survey that measures employee engagement and satisfaction, as well as organizational health.

This marks Prime’s eighth time to earn a spot on one of the Star Tribune’s Top Workplaces lists. This is the second time Prime has been honored this year, having been recognized nationally as a 2021 Top Workplace USA in January.

See a listing of the 2021 national standard setters

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

Related news

Stories

May 2, 2024

Prime discusses leading medically integrated dispensing model at Asembia

Connecting specialty pharmacies and providers to unlock optimal care and value

Stories

April 30, 2024

RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2024

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

Stories

April 24, 2024

New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care

Research published in the Journal of Managed Care & Specialty Pharmacy uses population data to fill gaps in social determinants of health data, providing a more complete understanding of a patient’s global health circumstances

View all news